BMY

Bristol Myers Squibb Co
74.575
0.125 (0.17%)
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.125 0.17% 74.575 11:39:10
Open Price Low Price High Price Close Price Prev Close
74.39 74.39 75.18 74.45
more quote information »

Recent News

Date Time Source Heading
2/06/20239:30IHNWFeaturedHempacco Pre-launches Snoop Dogg Brands at the Champs Trade Show in Las Vegas, February 8 - 11, Exhibiting with Death Row Vapes in Booth #1201
2/03/202306:59BWBristol Myers Squibb to Participate in the Guggenheim..
2/03/202302:24DJNTrending: Bristol Myers Squibb Beats 4Q Sales Expectations
2/02/202308:45EDGARCurrent Report Filing (8-k)
2/02/202306:59BWBristol Myers Squibb Reports Fourth Quarter and Full-Year..
1/27/202308:04DJNBristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
1/27/202307:05BWBristol Myers Squibb Receives Positive CHMP Opinion for..
1/27/202306:59BWBristol Myers Squibb Announces Positive CHMP Opinion for..
1/26/202308:00GLOBEiVexSol® Closes $23.8M Series A-3 Financing; Funds to..
1/26/202306:59BWBristol Myers Squibb Announces TRANSCEND CLL 004 Trial of..
1/19/202308:30BWThe Robert A. Winn Diversity in Clinical Trials Award..
1/09/202310:22EDGARCurrent Report Filing (8-k)
1/04/202317:26EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:26EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:25EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:25EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:24EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:24EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:22EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202317:22EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202307:05BWBristol Myers Squibb to Present at J.P. Morgan’s 41st Annual..
1/03/202306:59BWBristol Myers Squibb Completes Sale of Manufacturing..
12/16/202207:57DJNEvotec to Receive $26 Million in Expanded Bristol Myers..
12/15/202206:59BWBristol Myers Squibb to Report Results for Fourth Quarter..
12/12/202206:59BWBristol Myers Squibb Announces First Disclosures and New..
12/08/202216:16BWBristol Myers Squibb Announces Dividend Increase
12/06/202218:44EDGARStatement of Changes in Beneficial Ownership (4)
11/29/202208:00PRNUSEnvisagenics Announces Research Collaboration with Bristol..
11/21/202206:59BWBristol Myers Squibb Data at ASH 2022 Highlight Innovative..
11/10/202209:00PRNCAHealth Canada Approves Camzyos™ (mavacamten capsules) for..
11/09/202206:59BWBristol Myers Squibb to Participate in the Wolfe Research..
11/03/202207:00GLOBEKura Oncology Announces Financing Transactions with Bristol..
11/02/202206:59BWData Reinforcing Impact of Bristol Myers Squibb..
10/31/202206:59BWBristol Myers Squibb Announces Positive Topline Results of..
10/27/202217:08VWStrong Fundamentals Make Bristol-Myers Squibb Stock A Real..
10/27/202208:38TRMNAtlantic Equities Sticks to Its Buy Rating for Bristol Myers..
10/27/202208:35TRMNMorgan Stanley Sticks to Its Sell Rating for Bristol Myers..
10/27/202208:30PRNUSObsidian Therapeutics Announces Extension of Multi-Year..
10/26/202217:29DJNTrending: Britsol Myers Squibb 3Q Results Better Than..
10/26/202207:49EDGARCurrent Report Filing (8-k)
10/26/202202:00BWNew Zeposia (ozanimod) Data Highlight COVID-19 Outcomes and..
10/25/202222:35DJNBristol Myers's Third-Quarter Profit Rose, Revenue Declined
10/25/202219:31BWBristol Myers Squibb Reports Third Quarter Financial Results..
10/25/202213:04BWThe Robert A. Winn Diversity in Clinical Trials Award..
10/24/202206:59BWNew Data Presented at the American College of..
10/21/202207:52DJNBristol Myers: FDA to Review Camzyos to Reduce..
10/21/202206:59BWU.S. Food and Drug Administration (FDA) Accepts Supplemental..
10/19/202216:30BWBristol Myers Squibb Presents Data from CheckMate -76K..
10/07/202206:59BWBristol Myers Squibb Announces Change to Earnings Conference..
10/04/202208:17DJNAutolus Therapeutics Shares Jump After Cancer-Collaboration..
10/04/202207:00GLOBEAutolus Therapeutics Announces Collaboration with Bristol..